Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OSH
2926
DELISTED
Oak Street Health, Inc.
OSH
| $799K | ﹤0.01% |
14,722
+2,529
| +21% | +$141K |
|
2927
Intrepid Potash
IPI
$456M
| $796K | ﹤0.01% |
24,428
+1,246
| +5% | +$36.8K |
|
2928
UroGen Pharma
URGN
$1.86B
| $796K | ﹤0.01% |
40,853
-183
| -0.4% | -$3.88K |
|
2929
Bioventus
BVS
$892M
| $786K | ﹤0.01% |
+51,419
| New | +$732K |
|
2930
Spero Therapeutics
SPRO
$67.7M
| $786K | ﹤0.01% |
53,358
+1,527
| +3% | +$26.9K |
|
2931
MVB Financial
MVBF
$397M
| $785K | ﹤0.01% |
23,198
-921
| -4% | -$25.8K |
|
2932
SmartFinancial
SMBK
$896M
| $784K | ﹤0.01% |
36,169
+3,320
| +10% | +$70K |
|
|
ATHX
2933
DELISTED
Athersys, Inc. Common Stock
ATHX
| $784K | ﹤0.01% |
17,408
| – | – |
|
2934
InfuSystem Holdings
INFU
$184M
| $781K | ﹤0.01% |
38,312
| – | – |
|
|
LUNA
2935
DELISTED
Luna Innovations Incorporated
LUNA
| $781K | ﹤0.01% |
74,167
+2,517
| +4% | +$28.1K |
|
2936
Voyager Therapeutics
VYGR
$183M
| $777K | ﹤0.01% |
164,879
-5,011
| -3% | -$34.2K |
|
2937
Stereotaxis
STXS
$126M
| $776K | ﹤0.01% |
115,434
-1,130
| -1% | -$6.71K |
|
|
CTO
2938
CTO Realty Growth
CTO
$824M
| $772K | ﹤0.01% |
44,484
+48
| +0.1% | +$777 |
|
|
LJPC
2939
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $772K | ﹤0.01% |
181,934
-7,851
| -4% | -$43.3K |
|
2940
AMES National
ATLO
$271M
| $768K | ﹤0.01% |
30,007
+8,809
| +42% | +$215K |
|
2941
Southern Missouri Bancorp
SMBC
$852M
| $767K | ﹤0.01% |
19,448
| – | – |
|
2942
Viemed Healthcare
VMD
$447M
| $759K | ﹤0.01% |
74,966
+3,345
| +5% | +$31.5K |
|
|
CCRD
2943
DELISTED
CoreCard
CCRD
| $757K | ﹤0.01% |
18,484
+683
| +4% | +$28K |
|
|
FPI
2944
Farmland Partners
FPI
$408M
| $751K | ﹤0.01% |
66,929
-887
| -1% | -$10.1K |
|
|
SMMF
2945
DELISTED
Summit Financial Group, Inc.
SMMF
| $750K | ﹤0.01% |
28,242
+1,226
| +5% | +$29K |
|
2946
First Bancorp
FNLC
$396M
| $742K | ﹤0.01% |
25,411
| – | – |
|
|
STXB
2947
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $736K | ﹤0.01% |
32,969
+2,086
| +7% | +$42.5K |
|
|
APLT
2948
DELISTED
Applied Therapeutics
APLT
| $735K | ﹤0.01% |
39,146
+5,042
| +15% | +$109K |
|
2949
MeiraGTx Holdings
MGTX
$1.09B
| $735K | ﹤0.01% |
50,906
+6,174
| +14% | +$96.4K |
|
|
SPRB
2950
Spruce Biosciences
SPRB
$118M
| $733K | ﹤0.01% |
589
+51
| +9% | +$78.3K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.